Abstract
The hedgehog pathway, initially discovered in Drosophila by two Nobel laureates, Dr. Eric Wieschaus and Dr. Christiane Nüsslein-Volhard, is a major regulator for cell differentiation, tissue polarity, and cell proliferation. Studies from many laboratories—cluding ours—eal activation of this pathway in most basal cell carcinomas and nearly one third of extracutaneous human cancers, including medulloblastomas and gastrointestinal and prostate cancers. Even more exciting is the discovery and synthesis of specific signaling antagonists for the hedgehog pathway, which have significant clinical implications in novel cancer therapeutics. This review discusses the current understanding of the hedgehog signaling pathway and its activation in human cancers. It also discusses putative and confirmed signaling antagonists and their perspectives in therapeutic applications.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Nüsslein-Volhard C, Wieschaus E: Mutations affecting segment number and polarity in Drosophila. Nature 1980, 287:795–801.
Bale AE: Hedgehog signaling and human disease. Annu Rev Genomics Hum Genet 2002, 3:47–65.
Xie J: Hedgehog signaling in prostate cancer. Future Oncol 2005, 1:331–338.
Taipale J, Chen JK, Cooper MK, et al.: Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000, 406:1005–1009.
Martinelli DC, Fan CM: Gas1 extends the range of Hedgehog action by facilitating its signaling. Genes Dev 2007, 21:1231–1243.
Seppala M, Depew MJ, Martinelli DC, et al.: Gas1 is a modifier for holoprosencephaly and genetically interacts with sonic hedgehog. J Clin Invest 2007, 117:1575–1584.
Allen BL, Tenzen T, McMahon AP: The Hedgehog-binding proteins Gas1 and Cdo cooperate to positively regulate Shh signaling during mouse development. Genes Dev 2007, 21:1244–1257.
Okada A, Charron F, Morin S, et al.: Boc is a receptor for Sonic hedgehog in the guidance of commissural axons. Nature 2006, 444:369–373.
Tenzen T, Allen BL, Cole F, et al.: The cell surface membrane proteins Cdo and Boc are components and targets of the Hedgehog signaling pathway and feedback network in mice. Dev Cell 2006, 10:647–656.
Zhang W, Kang JS, Cole F, et al.: Cdo functions at multiple points in the Sonic Hedgehog pathway, and Cdo-deficient mice accurately model human holoprosencephaly. Dev Cell 2006, 10:657–665.
Yao S, Lum L, Beachy P: The ihog cell-surface proteins bind Hedgehog and mediate pathway activation. Cell 2006, 125:343–357.
Corbit KC, Aanstad P, Singla V, et al.: Vertebrate Smoothened functions at the primary cilium. Nature 2005, 437:1018–1021.
Huangfu D, Anderson KV: Cilia and Hedgehog responsiveness in the mouse. Proc Natl Acad Sci U S A 2005, 102:11325–11330.
Huangfu D, Liu A, Rakeman AS, et al.: Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 2003, 426:83–87.
Haycraft CJ, Banizs B, Aydin-Son Y, et al.: Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet 2005, 1:e53.
May SR, Ashique AM, Karlen M, et al.: Loss of the retrograde motor for IFT disrupts localization of SMO to cilia and prevents the expression of both activator and repressor functions of Gli. Dev Biol 2005, 287:378–389.
Incardona JP, Gruenberg J, Roelink H: Sonic Hedgehog induces the segregation of Patched and Smoothened in endosomes. Curr Biol 2002, 12:983–995.
Varjosalo M, Li SP, Taipale J: Divergence of Hedgehog signal transduction mechanism between Drosophila and mammals. Dev Cell 2006, 10:177–186.
Merchant M, Evangelista M, Luoh SM, et al.: Loss of the serine/threonine kinase fused results in postnatal growth defects and lethality due to progressive hydrocephalus. Mol Cell Biol 2005, 25:7054–7068.
Chen MH, Gao N, Kawakami T, Chuang PT: Mice deficient in the fused homolog do not exhibit phenotypes indicative of perturbed hedgehog signaling during embryonic development. Mol Cell Biol 2005, 25:7042–7053.
Eggenschwiler JT, Espinoza E, Anderson KV: Rab23 is an essential negative regulator of the mouse Sonic Hedgehog signalling pathway. Nature 2001, 412:194–198.
Reiter JF, Skarnes WC: Tectonic, a novel regulator of the Hedgehog pathway required for both activation and inhibition. Genes Dev 2006, 20:22–27.
Svärd J, Henricson KH, Persson-Lek M, et al.: Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell 2006, 10:187–197
Barnfield PC, Zhang X, Thanabalasingham V, et al.: Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms. Differentiation 2005, 73:397–405.
Sasaki H, Hui C, Nakafuku M, Kondoh H: A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 1997, 124:1313–1322.
Sheng T, Chi S, Zhang X, Xie J: Regulation of Gli1 localization by the cAMP/protein kinase A signaling axis through a site near the nuclear localization signal. J Biol Chem 2006, 281:9–12.
Stecca B, Mas C, Clement V, et al.: Melanomas require Hedgehog-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci U S A 2007, 104:5895–5900.
Wang B, Li Y: Evidence for the direct involvement of taTrCP in Gli3 protein processing. Proc Natl Acad Sci U S A, 2006, 103:33–38.
Kasper M, Schnidar H, Neill GW, et al.: Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol Cell Biol 2006, 26:6283–6298.
Cheng SY, Bishop JM: Suppressor of Fused represses Gli-mediated transcription by recruiting the SAP18-mSin3 corepressor complex. Proc Natl Acad Sci U S A 2002, 99:5442–5447.
Lindstrom E, Shimokawa T, Toftgard R, Zaphiropoulos PG: PTCH mutations: distribution and analyses. Hum Mutat 2006, 27:215–219.
Rubin LL, de Sauvage FJ: Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 2006, 5:1026–1033.
Reifenberger J, Wolter M, Knobbe CB, et al.: Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005, 152:43–51.
Athar M, Li C, Tang X, et al.: Inhibition of Smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res 2004, 64:7545–7552.
Berman DM, Karhadkar SS, Maitra A, et al.: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425:846–851.
Watkins DN, Berman DM, Burkholder SG, et al.: Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422:313–317.
Huang S, He J, Zhang X, et al.: Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis 2006, 27:1334–1340.
Ma X, Chen K, Huang S, et al.: Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 2005, 26:1698–1705.
Thayer SP, di Magliano MP, Heiser PW, et al.: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425:851–856.
Pasca di Magliano M, Sekine S, Ermilov A, et al.: Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 2006, 20:3161–3173.
Clement V, Sanchez P, de Tribolet N, et al.: HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007, 17:165–172.
Sheng T, Li C, Zhang X, et al.: Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer 2004, 3:29.
Karhadkar SS, Bova GS, Abdallah N, et al.: Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004, 431:707–712.
Kubo M, Nakamura M, Tasaki A, et al.: Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 2004, 64:6071–6074.
Sanchez P, Ruiz i Altaba A: In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice. Mech Dev 2005, 122:223–230.
Williams JA, Guicherit OM, Zaharian BI, et al.: Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci U S A 2003, 100:4616–4621.
Frank-Kamenetsky M, Zhang XM, Bottega S, et al.: Smallmolecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. J Biol 2002, 1:10.
Chen JK, Taipale J, Young KE, et al.: Small molecule modulation of Smoothened activity. Proc Natl Acad Sci U S A 2002, 99:14071–14076.
Lauth M, Bergstrom A, Shimokawa T, Toftgard R: Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci U S A 2007, 104:8455–8460.
Bijlsma MF, Spek CA, Zivkovic D, et al.: Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol, 2006, 4:e232.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xie, J. Hedgehog signaling pathway: Development of antagonists for cancer therapy. Curr Oncol Rep 10, 107–113 (2008). https://doi.org/10.1007/s11912-008-0018-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11912-008-0018-7